Lion TCR
Singapore’s Lion TCR secures $40M in Series B2 financing led by Chinese investors
Lion TCR, a Singapore-based clinical-stage T-cell immunotherapy company, has announced the successful completion of its $40 million Series B2 financing round. Guangzhou…
June 27, 2023
Vietnam’s FEBE Ventures unveils $75M second fund
December 1, 2023
Grab-backed GXBank officially open to Malaysians
November 30, 2023
Singapore’s Fr8Labs secures $1.5M seed funding for market expansion
November 30, 2023
Vietnam’s FEBE Ventures unveils $75M second fund
December 1, 2023
Grab-backed GXBank officially open to Malaysians
November 30, 2023
Singapore’s Fr8Labs secures $1.5M seed funding for market expansion
November 30, 2023